𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical, neurophysiological and immunological evidence of polyneuropathy in patients with monoclonal gammopathies

✍ Scribed by Magnus Vrethem; Mabel Cruz; Huang Wen-Xin; Claes Malm; Helen Holmgren; Jan Ernerudh

Book ID
118931819
Publisher
Elsevier Science
Year
1993
Tongue
English
Weight
678 KB
Volume
114
Category
Article
ISSN
0022-510X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Clinical features, evaluation, and treat
Clinical features, evaluation, and treatment of patients with polyneuropathy associated with monoclonal gammopathy of undetermined significance (MGUS)
✍ Kenneth C. Gorson πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 32 KB πŸ‘ 2 views

A number of common disorders of the peripheral nervous system are closely linked to a monoclonal gammopathy. In a minority of patients, the neuropathy represents the sentinel feature of a malignant plasma cell dyscrasia, such as multiple myeloma or its osteosclerotic variant, Waldenstrom's disease,

Long-term clinical and neurophysiologica
Long-term clinical and neurophysiological follow-up of patients with peripheral, neuropathy associated with benign monoclonal gammopathy
✍ Sawanthana Ponsford; Hugh Willison; Jean Veitch; Richard Morris; P.K. Thomas πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 216 KB πŸ‘ 2 views

The incidence of hematological malignancy in patients with monoclonal gammopathy of undetermined significance (MGUS) has been assessed as 17% to 25%. To ascertain whether this is true of neuropathy associated with MGUS, a long-term (5-42 years) retrospective clinical and neurophysiological follow-up